These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 9583422)

  • 1. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and risk of colon and rectal cancer.
    Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin.
    Nichols HB; Trentham-Dietz A; Hampton JM; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1212-8. PubMed ID: 15894674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study.
    Lin J; Zhang SM; Cook NR; Manson JE; Buring JE; Lee IM
    Am J Epidemiol; 2007 Apr; 165(7):794-801. PubMed ID: 17215381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and colorectal cancer risk.
    La Vecchia C; Negri E; Decarli A; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1007-10. PubMed ID: 9419395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coffee consumption and the risk of breast cancer.
    Tavani A; Pregnolato A; La Vecchia C; Favero A; Franceschi S
    Eur J Cancer Prev; 1998 Feb; 7(1):77-82. PubMed ID: 9511854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS).
    Contraception; 1997 Nov; 56(5):275-84. PubMed ID: 9437555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and colorectal cancer risk: a meta-analysis.
    Fernandez E; La Vecchia C; Balducci A; Chatenoud L; Franceschi S; Negri E
    Br J Cancer; 2001 Mar; 84(5):722-7. PubMed ID: 11237397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives and breast cancer: a case-control study with hospital and community controls.
    Schildkraut JM; Hulka BS; Wilkinson WE
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):395-402. PubMed ID: 2381616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoids and colorectal cancer in Italy.
    Rossi M; Negri E; Talamini R; Bosetti C; Parpinel M; Gnagnarella P; Franceschi S; Dal Maso L; Montella M; Giacosa A; La Vecchia C
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1555-8. PubMed ID: 16896049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and hormone replacement therapy may protect against colorectal cancer.
    Contracept Rep; 1996 Nov; 7(4):10. PubMed ID: 12291811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of exogenous hormones by women and colorectal cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study.
    Hannaford P; Elliott A
    Contraception; 2005 Feb; 71(2):95-8. PubMed ID: 15707557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific differences in the relationship between oral contraceptive use and breast cancer.
    Wingo PA; Lee NC; Ory HW; Beral V; Peterson HB; Rhodes P
    Obstet Gynecol; 1991 Aug; 78(2):161-70. PubMed ID: 2067757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.